REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$6.60
+0.23%
Mkt Cap $473.31M
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (30 analysts)
$20.00
Range $12.00 – $29.00
Implied Upside
+203.3%
Consensus $20.00 vs current $6.60
NASDAQ·Healthcare·Biotechnology
$6.60
+0.23%
Mkt Cap $473.31M
Buy
9
Hold
1
Sell
0
Price Target (30 analysts)
$20.00
Range $12.00 – $29.00
+203.3%
Consensus $20.00 vs current $6.60